Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort-Reference-Cited by-同舟云学术

Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort

Published:2018-09-24 Issue:12 Volume:84 Page:2811-2823
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Laville Solène M.¹^ORCID,Metzger Marie¹,Stengel Bénédicte¹,Jacquelinet Christian¹²,Combe Christian³⁴,Fouque Denis⁵,Laville Maurice⁵,Frimat Luc⁶⁷,Ayav Carole⁶,Speyer Elodie¹,Robinson Bruce M.⁸,Massy Ziad A.¹⁹,Liabeuf Sophie¹⁰¹¹^ORCID,

Affiliation:

1. CESP Centre for Research in Epidemiology and Population Health; Univ Paris-Saclay, Univ Paris Sud, UVSQ, UMRS 1018; F-94807 Villejuif France

2. Agence de la Biomédecine; Saint-Denis France

3. Service de Néphrologie Transplantation Dialyse Aphérèse; Centre Hospitalier Universitaire de Bordeaux; Bordeaux France

4. INSERM, U1026; Univ Bordeaux Segalen; Bordeaux France

5. Department of Nephrology; Centre Hospitalier Lyon Sud, Univ Lyon, UCBL, Carmen; F-69495 Pierre-Bénite France

6. Clinical Epidemiology; Inserm CIC-EC, CHU de Nancy; Vandoeuvre-lès-Nancy France

7. Nephrology Department; CHU de Nancy Vandoeuvre-lès-Nancy France

8. Arbor Research Collaborative for Health; Ann Arbor Michigan USA

9. Nephrology Department; CHU Ambroise Pare; Boulogne France

10. Pharmacology department; Amiens University Hospital; Amiens France

11. INSERM U1088; Jules Vernes University; Amiens France

Funder

Agence Nationale de la Recherche

Agence Nationale de Sécurité du Médicament et des Produits de Santé

Amgen

Baxter International

Fresenius Medical Care

GlaxoSmithKline

Lilly France

Merck Sharp and Dohme

Otsuka Pharmaceutical

Programme Hospitalier de Recherche Clinique

Sanofi-Genzyme

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13738/fullpdf

Reference33 articles.

1. Chronic kidney disease;Levey;The Lancet,2012

2. Drug use and dosing in chronic kidney disease;Hassan;Ann Acad Med Singapore,2009

3. A synopsis of clinical pharmacokinetic alterations in advanced CKD;Nolin;Semin Dial,2015

4. Drug dosing adjustments in patients with chronic kidney disease;Munar;Am Fam Physician,2007

5. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group;Kidney Int Suppl,2013

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recipients of public assistance with advanced chronic kidney disease: insights into receiving a presentation of kidney replacement therapy options and polypharmacy from Japanese investigators with innovative network about kidney disease study;Clinical and Experimental Nephrology;2024-08-22

2. De-indexed estimated glomerular filtration rates for the dosing of oral antidiabetic drugs in patients with chronic kidney disease;Frontiers in Pharmacology;2024-07-04

3. Controversies and practical management of patients with gout and chronic kidney disease;Kidney International;2024-07

4. Prevention of Chronic Kidney Disease and Its Complications in Older Adults;Drugs & Aging;2024-06-26

5. Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease;Clinical Kidney Journal;2024-06-14